SCHEMBL19922945

SCHEMBL19922945

N#Cc1cccc(C[C@H](N)C(=O)N2CCC(c3ccccc3)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 6/20 0.60
DPP4 P27487 5/20 0.60
DPP8 Q6V1X1 4/20 0.60
DPP9 Q86TI2 4/20 0.60
FAP Q12884 2/20 0.60
NR3C1 P04150 1/20 0.48
SCD5 Q86SK9 1/20 0.47
MGLL Q99685 1/20 0.46
OPRD1 P41143 1/20 0.46
SMYD3 Q9H7B4 1/20 0.46
OPRK1 P41145 1/20 0.45
HDAC8 Q9BY41 2/20 0.44
TACR1 P25103 1/20 0.44
FOLH1 Q04609 1/20 0.44
HPN P05981 1/20 0.44
HGFAC Q04756 1/20 0.44
ST14 Q9Y5Y6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19922947 1.00 DPP7 (0.60) DPP7DPP4DPP8DPP9FAP
SCHEMBL2376093 0.85 HDAC8 (0.59) DPP7DPP4DPP8DPP9FAP
SCHEMBL2376087 0.85 HDAC8 (0.59) DPP7DPP4DPP8DPP9FAP
SCHEMBL19923019 0.85 HPN (0.50) DPP7DPP4DPP8DPP9FAP
SCHEMBL19923016 0.85 HPN (0.50) DPP7DPP4DPP8DPP9FAP
SCHEMBL19923030 0.84 DPP7 (0.61) DPP7DPP4DPP8DPP9FAP
SCHEMBL19923028 0.84 DPP7 (0.61) DPP7DPP4DPP8DPP9FAP
SCHEMBL8385358 0.84 DPP7 (0.72) DPP7DPP4DPP8DPP9FAP
SCHEMBL18049265 0.83 DPP7 (0.57) DPP7DPP4DPP8DPP9FAP
SCHEMBL18049261 0.83 DPP7 (0.57) DPP7DPP4DPP8DPP9FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169676-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES WASHINGTON UNIVERSITY (US) 2022-06-02 US disclosed
US-11130780-B2 Inhibitors of growth factor activation enzymes WASHINGTON UNIVERSITY (US) 2021-09-28 US disclosed
US-20180066015-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES WASHINGTON UNIVERSITY (US) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130780-B2 Inhibitors of growth factor activation enzymes HDGF, MMP7, HGF DPP7 354/4885DPP4 682/4885DPP8 334/4885
US-20220169676-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES HDGF, MMP7, HGF DPP7 354/4885DPP4 682/4885DPP8 334/4885
US-20180066015-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES HDGF, MMP7, HGF DPP7 354/4885DPP4 682/4885DPP8 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.